2019 annual financial data
Fate Therapeutics, Inc. 2019 Operating margin
Fate Therapeutics, Inc. 2019 operating margin with verified reported values.
Direct answer
Operating margin was -943.14%.
Operating income was -100,727,000 USD and net income was -98,149,000 USD.
Operating cash flow was -83,175,000 USD.
Get free Fate Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,680,000 USD
- Operating income
- -100,727,000 USD
- Net income
- -98,149,000 USD
- Operating cash flow
- -83,175,000 USD